PR-POSITIVE BREAST CANCER
Clinical trials for PR-POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new PR-POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for PR-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to wipe out breast cancer before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether giving a combination of three drugs—neratinib, an aromatase inhibitor (letrozole or anastrozole), and trastuzumab—before surgery can completely eliminate invasive breast cancer in postmenopausal women with ER-positive, HER2-positive breast ca…
Matched conditions: PR-POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Ruth O'Regan • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New app aims to help breast cancer patients stick with Long-Term treatment
Knowledge-focused Recruiting nowThis study is testing a new web and mobile app called SHIELD, designed to support women with hormone receptor-positive breast cancer who are on long-term hormone therapy. The goal is to see if the app is easy to use and helpful for managing treatment. About 30 women will particip…
Matched conditions: PR-POSITIVE BREAST CANCER
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC